15 patents
Utility
VSIG8-based chimeric proteins
5 Dec 23
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 1 Nov 21
Utility
Heterodimeric proteins and uses thereof
10 Oct 23
The present invention relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 24 Mar 21
Utility
Heterodimeric proteins for modulating gamma delta T cells
9 May 23
The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 1 Jun 22
Utility
Methods of making and using extracellular domain-based chimeric proteins
17 May 22
The present invention relates, inter alia, to compositions and methods, including chimeric proteins and combination therapies that find use in the treatment of disease, such as cancer and/or an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 27 Feb 18
Utility
CSF1R-CD40L chimeric proteins
8 Mar 22
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of colony stimulating factor 1 receptor (CSF1R) and their use in the treatment of diseases, such as immunotherapies for cancer and/or an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 27 Feb 18
Utility
CSF1R-based chimeric proteins
8 Mar 22
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of colony stimulating factor 1 receptor (CSF1R) and their use in the treatment of diseases, such as immunotherapies for cancer and/or an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 6 Nov 19
Utility
VSIG8-based chimeric proteins
7 Dec 21
The present invention relates, in part, to chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 27 Feb 18
Utility
VSIG8-based chimeric proteins
7 Dec 21
The present invention relates, in part, to chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 28 Oct 19
Utility
Heterodimeric proteins for modulating gamma delta T cells
24 Aug 21
The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 13 Jan 20
Utility
Heterodimeric proteins and uses thereof
4 May 21
The present invention relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 16 Sep 19
Utility
Heterodimeric proteins for modulating gamma delta T cells
27 Apr 21
The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 3 Jun 20
Utility
TIGIT- and light-based chimeric proteins
23 Feb 21
The present invention relates, inter alia, to compositions and methods, including TIGIT- and/or LIGHT-based chimeric proteins that find use in the treatment of disease, such as cancer and an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 10 Sep 20
Utility
TIGIT- and light-based chimeric proteins
26 Jan 21
The present invention relates, inter alia, to compositions and methods, including TIGIT- and/or LIGHT-based chimeric proteins that find use in the treatment of disease, such as cancer and an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 24 Apr 20
Utility
FLT3L-based chimeric proteins
21 Sep 20
The present invention relates, inter alia, to compositions and methods, including chimeric proteins comprising an extracellular domain of FMS like tyrosine kinase 3 ligand (FLT3L) and an extracellular domain of a Type II transmembrane protein that find use in the treatment of disease, such as cancer.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 12 Sep 19
Utility
CSF1R-based chimeric proteins
23 Dec 19
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of colony stimulating factor 1 receptor (CSF1R) and their use in the treatment of diseases, such as immunotherapies for cancer and/or an inflammatory disease.
Taylor Schreiber, George Fromm, Suresh De Silva
Filed: 17 Dec 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first